A novel IL-1RA-PEP fusion protein alleviates blood-brain barrier disruption after ischemia-reperfusion in male rats
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A novel IL-1RA-PEP fusion protein alleviates blood-brain barrier disruption after ischemia-reperfusion in male rats
Authors
Keywords
Ischemia-reperfusion injury, Blood-brain barrier, IL-1RA-PEP fusion protein, Middle cerebral artery occlusion, Angiogenesis
Journal
Journal of Neuroinflammation
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-15
DOI
10.1186/s12974-018-1058-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel IL-1RA-PEP fusion protein with enhanced brain penetration ameliorates cerebral ischemia-reperfusion injury by inhibition of oxidative stress and neuroinflammation
- (2017) Dong-Dong Zhang et al. EXPERIMENTAL NEUROLOGY
- D-allose protects the blood brain barrier through PPARγ-mediated anti-inflammatory pathway in the mice model of ischemia reperfusion injury
- (2016) Tao Huang et al. BRAIN RESEARCH
- The blood–brain barrier after stroke: Structural studies and the role of transcytotic vesicles
- (2016) Michael J Haley et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers
- (2016) Ralf G Rempe et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Cell-penetrating peptides as noninvasive transmembrane vectors for the development of novel multifunctional drug-delivery systems
- (2016) Dongdong Zhang et al. JOURNAL OF CONTROLLED RELEASE
- Ischemia-induced Angiogenesis is Attenuated in Aged Rats
- (2016) Yaohui Tang et al. Aging and Disease
- Astrocytic TYMP and VEGFA drive blood–brain barrier opening in inflammatory central nervous system lesions
- (2015) Candice Chapouly et al. BRAIN
- Factors controlling permeability of the blood–brain barrier
- (2015) Mohammed M. A. Almutairi et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Neutralizing anti-interleukin-1β antibodies modulate fetal blood–brain barrier function after ischemia
- (2015) Xiaodi Chen et al. NEUROBIOLOGY OF DISEASE
- IL-1 receptor antagonist attenuates neonatal lipopolysaccharide-induced long-lasting learning impairment and hippocampal injury in adult rats
- (2015) Kuo-Mao Lan et al. TOXICOLOGY LETTERS
- Orosomucoid1: Involved in vascular endothelial growth factor-induced blood–brain barrier leakage after ischemic stroke in mouse
- (2014) Li Wu et al. BRAIN RESEARCH BULLETIN
- Novel insights into the development and maintenance of the blood–brain barrier
- (2014) Britta Engelhardt et al. CELL AND TISSUE RESEARCH
- Recombinant Human Interleukin-1 Receptor Antagonist in Severe Traumatic Brain Injury: A Phase II Randomized Control Trial
- (2014) Adel Helmy et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial
- (2014) Navneet Singh et al. Journal of Neuroinflammation
- Interleukin-1β induces an inflammatory response and the breakdown of the endothelial cell layer in an improved human THBMEC-based in vitro blood–brain barrier model
- (2014) Josephine Labus et al. JOURNAL OF NEUROSCIENCE METHODS
- The blood-brain barrier: Structure, function and therapeutic approaches to cross it
- (2014) Marta Tajes et al. MOLECULAR MEMBRANE BIOLOGY
- Cell penetrating peptides: Efficient vectors for delivery of nanoparticles, nanocarriers, therapeutic and diagnostic molecules
- (2014) Samad Mussa Farkhani et al. PEPTIDES
- HSP27 Protects the Blood-Brain Barrier Against Ischemia-Induced Loss of Integrity
- (2013) Rehana K. Leak et al. CNS & Neurological Disorders-Drug Targets
- Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery
- (2013) Feihu Wang et al. JOURNAL OF CONTROLLED RELEASE
- The growth factor progranulin attenuates neuronal injury induced by cerebral ischemia-reperfusion through the suppression of neutrophil recruitment
- (2013) Yusuke Egashira et al. Journal of Neuroinflammation
- Tight Junction in Blood-Brain Barrier: An Overview of Structure, Regulation, and Regulator Substances
- (2012) Wei-Ye Liu et al. CNS Neuroscience & Therapeutics
- Neurovascular Matrix Metalloproteinases and the Blood-Brain Barrier
- (2012) Ji Hae Seo et al. CURRENT PHARMACEUTICAL DESIGN
- Interleukin-1 Beta Increases Activity of Human Endothelial Progenitor Cells: Involvement of PI3K-Akt Signaling Pathway
- (2012) Lin Yang et al. INFLAMMATION
- Neurological Diseases in Relation to the Blood–Brain Barrier
- (2012) Gary A Rosenberg JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Blood-brain barrier, reperfusion injury, and hemorrhagic transformation in acute ischemic stroke
- (2012) R. Khatri et al. NEUROLOGY
- Interleukin-1 and Stroke: Biomarker, Harbinger of Damage, and Therapeutic Target
- (2011) Adam Denes et al. CEREBROVASCULAR DISEASES
- Specific Role of Tight Junction Proteins Claudin-5, Occludin, and ZO-1 of the Blood–Brain Barrier in a Focal Cerebral Ischemic Insult
- (2011) Haixia Jiao et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Blood–Brain Barrier Breakdown in Acute and Chronic Cerebrovascular Disease
- (2011) Yi Yang et al. STROKE
- The role of interleukin-1 in seizures and epilepsy: A critical review
- (2009) K. Rijkers et al. EXPERIMENTAL NEUROLOGY
- Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease
- (2008) M. C. Pott Godoy et al. BRAIN
- The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective
- (2008) Solomon S Shaftel et al. Journal of Neuroinflammation
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started